Steiner R A
Kantonales Frauenspital Fontana, Chur.
Ther Umsch. 1999 Oct;56(10):616-23. doi: 10.1024/0040-5930.56.10.616.
Cancer in pregnancy represents a complicated scenario and a unique challenge to the pregnant patient, her family and the physicians. Extraordinary decisions are forced upon the woman and all participants involved with her care. They must address medical, religions, social, ethical and emotional concerns of the mother and her family. Because of the low incidence of malignant disease in pregnancy it is not possible to develop a large personal experience. The most common malignancies in pregnancy are cancers of the cervix and the breast, followed by melanomas and ovarian cancer. After stratification for stage all gynaecological malignancies have a similar prognosis as cancers in nonpregnant patients, provided they are treated correctly. The general principle is to treat the cancer and to allow the pregnancy to proceed until adequate foetal maturity has been achieved. In cervical cancer a delay in therapy of several weeks revealed no adverse effects on treatment outcome. Generally caesarean section should be the delivery method of choice. In breast cancer diagnoses is typically delayed for 5 to 7 months for various reasons. Therefore work-up of a mass discovered during pregnancy has to be as strict and complete as outside pregnancy. Breast-conservation therapy remains an option even in pregnancy but adjuvant radiotherapy should be started after the child has been born. Even chemotherapy is possible although the first trimester is the most critical time resulting in a 10-20% malformation rate as compared with a rate of 3% in the general population. Chemotherapy in the second and third trimester may result in intrauterine growth restriction. Breast feeding is contraindicated in women receiving chemotherapy. Therapeutic abortion does not improve survival. Most ovarian cancers diagnosed in pregnancy are of low grade and early stage (Stage I). Work-up and treatment involving surgery and chemotherapy follows the same guidelines as in the nonpregnant woman. In order to arrive at the optimal decision, the patient and her family have to be optimally informed.
妊娠期癌症是一种复杂的情况,对孕妇及其家人以及医生来说都是独特的挑战。女性以及所有参与其护理的人员都不得不做出非凡的决定。他们必须处理母亲及其家人在医学、宗教、社会、伦理和情感方面的问题。由于妊娠期恶性疾病的发病率较低,很难积累丰富的个人经验。妊娠期最常见的恶性肿瘤是宫颈癌和乳腺癌,其次是黑色素瘤和卵巢癌。按分期分层后,所有妇科恶性肿瘤只要治疗得当,其预后与非妊娠患者的癌症相似。一般原则是治疗癌症,并让妊娠继续进行,直到胎儿达到足够的成熟度。在宫颈癌中,治疗延迟几周对治疗结果没有不利影响。一般来说,剖宫产应是首选的分娩方式。在乳腺癌中,由于各种原因,诊断通常会延迟5至7个月。因此,对孕期发现的肿块进行的检查必须像非孕期一样严格和全面。即使在孕期,保乳治疗仍是一种选择,但辅助放疗应在孩子出生后开始。甚至化疗也是可行的,尽管孕早期是最关键的时期,与一般人群3%的畸形率相比,此时化疗导致的畸形率为10 - 20%。孕中期和孕晚期化疗可能导致胎儿宫内生长受限。接受化疗的女性禁止母乳喂养。治疗性流产并不能提高生存率。大多数在孕期诊断出的卵巢癌为低级别且处于早期(I期)。涉及手术和化疗的检查与治疗遵循与非妊娠女性相同的指南。为了做出最佳决策,必须让患者及其家人充分了解情况。